ASP Isotopes (NASDAQ:ASPI) Sets New 52-Week Low After Insider Selling

Key Points

• ASP Isotopes fell to a new 52-week low of $3.42 after COO Robert Ainscow sold 8,438 shares at an average price of $4.29. The sale was made to cover tax withholding tied to vested equity awards and reduced his position by 0.37%.
• Analyst sentiment remains mixed, with two Buy ratings and one Sell rating producing a consensus Hold rating and an average price target of $13.00.
• The company reported a quarterly loss of $0.28 per share, missing the $0.17 consensus estimate, although revenue of $5.12 million exceeded expectations. ASP Isotopes continues to show substantial losses, including a negative net margin of 427.98%.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) reached a new 52-week low during trading on Friday after an insider sold shares in the company. The company traded as low as $3.42 and last traded at $3.4280, with a volume of 605382 shares changing hands. The stock had previously closed at $3.59.

Specifically, COO Robert Ainscow sold 8,438 shares of ASP Isotopes stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $4.29, for a total transaction of $36,199.02. Following the transaction, the chief operating officer owned 2,248,441 shares in the company, valued at approximately $9,645,811.89. The trade was a 0.37% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Wall Street Zen upgraded ASP Isotopes from a "strong sell" rating to a "sell" rating in a research note on Saturday, August 22nd. Weiss Ratings restated a "sell (d-)" rating on shares of ASP Isotopes in a research report on Wednesday, June 24th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $13.00.

ASP Isotopes Stock Performance

The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.85 and a current ratio of 3.87. The company has a market capitalization of $525.09 million, a P/E ratio of -2.59 and a beta of 3.59. The business's fifty day simple moving average is $4.21 and its 200-day simple moving average is $5.16.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last released its quarterly earnings data on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.11). The company had revenue of $5.12 million for the quarter, compared to the consensus estimate of $4.47 million. ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Quantbot Technologies LP bought a new stake in ASP Isotopes in the 3rd quarter valued at $34,000. BNP Paribas Financial Markets boosted its position in ASP Isotopes by 84.9% during the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company's stock worth $41,000 after purchasing an additional 2,548 shares during the period. State of Wyoming acquired a new position in shares of ASP Isotopes in the first quarter valued at $29,000. Allworth Financial LP acquired a new position in shares of ASP Isotopes in the second quarter valued at $51,000. Finally, Legal & General Group Plc raised its position in shares of ASP Isotopes by 30.4% in the third quarter. Legal & General Group Plc now owns 8,377 shares of the company's stock valued at $81,000 after purchasing an additional 1,953 shares during the period. 16.80% of the stock is currently owned by institutional investors.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.